CRP and Neurodevelopmental delay: In the post-hoc study of roxadustat in patients with NDD-CKD and HDD-CKD, while the maintenance dose of roxadustat was not affected by baseline high-sensitive (hs)-CRP, the maintenance dose of darbepoetin alfa did show an increasing trend in the high hs-CRP group [11, 12].